BROWSE·page 287 of 611

Browse EX-10 agreements

7,325 matching material contract exhibits.


EX-10.1

DataMeds AI, Inc.

AMENDED AND RESTATED LETTER OF INTENT

July 29, 2026

** **

This Amended and Restated Letter of Intent (this “ LOI”) sets forth our current proposal with regard to the proposed combination (the “Transaction”) of DataMEDS AI, Inc., a reporting public company incorporated in Delaware and f/k/a Wellgistics Health, Inc. (“MEDS”), that has entered into a definitive license agreement for the license of pharmaceutical distribution-related blockchain-enabled technology with Datavault AI Inc. (“DVLT”), a public company that is the owner of intellectual property enabling data monetization, credentialing, digital engagement and tokenization of real-world assets, with healthcare utilization technology enablement being referred to as Datavault AI Health (“DVLH” which excludes all intellectual property already licensed to Vivasor, Inc. and Scilex Holding Company and/or Quantum Scan Holdings, Inc.), EOS Technology Holdings, Inc. (“EOS”), a private company that owns intellectual property related to the biometric verification of delivery and/or use of pharmaceutical drugs origina

…

EX-10.1·8-K·CIK 2030763·ACC 0001493152-26-036005·Filed Aug 04, 2026, 16:30 ET

EX-10.1

HACKETT GROUP, INC.

Execution Verison

FOURTH AMENDED AND RESTATED CREDIT AGREEMENT

Dated as of August 3, 2026

among

THE HACKETT GROUP, INC.,

as the Borrower,

THE SUBSIDIARIES OF THE BORROWER PARTY HERETO,

as the Guarantors,

BANK OF AMERICA, N.A.,

as Administrative Agent, Swingline Lender and an L/C Issuer,

THE OTHER L/C ISSUERS PARTY HERETO,

and

THE LENDERS PARTY HERETO

BOFA SECURITIES, INC.,
as Sole Lead Arranger and Sole Bookrunner

Florida documentary stamp tax in the amount of $2,450.00 were paid directly to the Department of Revenue in connection with the credit facility provided herein.

Certificate of Registration No. 26-8000694050-8

540466581.6


TABLE OF CONTENTS

SectionPage

…

EX-10.1·8-K·CIK 1057379·ACC 0001193125-26-332885·Filed Aug 04, 2026, 16:22 ET

EX-10.1

3D SYSTEMS CORP

**3D SYSTEMS CORPORATION **

**EXECUTIVE SEVERANCE AND RELEASE AGREEMENT **

THIS EXECUTIVE SEVERANCE AND RELEASE AGREEMENT (“Agreement”) is entered into by and between 3D Systems Corporation, (the “Employer” or “Company”) and Dr. Jeffrey A. Graves (the “Executive”) (the Employer and the Executive are collectively referred to as the “Parties”) as of August 4, 2026 (the “Execution Date”).

WHEREAS, the Employer and the Executive entered into that certain Employment Agreement, dated May 11, 2020 (the “Employment Agreement”), pursuant to which the Executive has served as the Employer’s President and Chief Executive Officer;

WHEREAS, the Employer is terminating the Executive’s employment without Cause (as defined in the Employment Agreement) pursuant to Section 4.3 of the Employment Agreement, effective as of the date the Executive’s successor becomes President and Chief Executive Officer of the Company (the “Termination Date”);

…

EX-10.1·8-K·CIK 910638·ACC 0001193125-26-332856·Filed Aug 04, 2026, 16:16 ET

EX-10.2

Oncotelic Therapeutics, Inc.

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE PURCHASE AGREEMENT)), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S UNDER SAID ACT OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

…

EX-10.2·8-K·CIK 908259·ACC 0001493152-26-035999·Filed Aug 04, 2026, 16:15 ET

EX-10.1

Oncotelic Therapeutics, Inc.

SECURITIES PURCHASE AGREEMENT

This **SECURITIES PURCHASE AGREEMENT **(the “Agreement”), dated as of August 3, 2026, by and between ONCOTELIC THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 29397 Agoura Road Suite 107, Agoura Hills, CA 91301 (the “Company”), and PACIFIC PIER CAPITAL II, LP, a Delaware limited partnership, with its address at 285 East Imperial Highway, Suite 203, Fullerton, CA 92835 (the “Buyer”).

WHEREAS:

A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506(b) promulgated by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act;

…

EX-10.1·8-K·CIK 908259·ACC 0001493152-26-035999·Filed Aug 04, 2026, 16:15 ET

EXHIBIT 10.22.6.5

PRIMEENERGY RESOURCES CORP

** Exhibit **10.22.6.5

BORROWING BASE AGREEMENT

This BORROWING BASE AGREEMENT (this “Agreement”), dated as of August 3, 2026 (the “Agreement Effective Date”), is among PRIMEENERGY RESOURCES CORPORATION, a Delaware corporation (the “Borrower”), CITIBANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”), each Guarantor party hereto and each Lender party hereto.

RECITALS:

A.         The Borrower, the Lenders and the Administrative Agent are parties to a Fourth Amended and Restated Credit Agreement dated as of July 5, 2022 (as the same has been or may be amended, restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”).

B.         The parties hereto have agreed, subject to the terms hereof, to certain terms with respect to the Borrowing Base as more fully set forth herein.

AGREEMENT:

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto hereby agree as follows:

…

EX-10.2265·8-K·CIK 56868·ACC 0001437749-26-025662·Filed Aug 04, 2026, 16:13 ET

EX-10.1

Angi Inc.

AMENDED AND RESTATED PERFORMANCE STOCK UNIT AGREEMENT

This AMENDED AND RESTATED PERFORMANCE STOCK UNIT AGREEMENT (this “Agreement”), dated as of August 3, 2026 (“Amendment Effective Date”), is entered into by and between Angi Inc. (“ANGI”) and Jeffrey W. Kip (“Executive”), and modifies the Performance Stock Unit Agreement, dated as of April 5, 2024 (the “Effective Date”), between ANGI and Executive.

Reference is made to the Employment Agreement (“Employment Agreement”), by and between Executive and ANGI, dated as of November 13, 2023, as amended as of the Effective Date. Capitalized terms used in this Agreement, to the extent not defined, shall have the meanings set forth in the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan (the “Plan”).

1.            Definitions

(a)            “Cause” shall have the meaning ascribed to such term in the Employment Agreement.

(b)            “FMV” means the volume-weighted average closing price of a Share on the NASDAQ Stock Market over thirty consecutive trading days, as reported by Bloomberg.

…

EX-10.1·8-K·CIK 1705110·ACC 0001705110-26-000077·Filed Aug 04, 2026, 16:06 ET

EXHIBIT 10.1

Celanese Corp

Execution Version

FIRST AMENDMENT TO CREDIT AGREEMENT

FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of July 31, 2026 (this “First Amendment”), by and among Celanese Corporation, a Delaware corporation (“Holdings”), Celanese US Holdings LLC, a Delaware limited liability company (the “Company”), the Subsidiary Guarantors party hereto, Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”) for the Lenders (as defined below) and each of the Consenting Lenders (as defined below).

W I T N E S S E T H:

WHEREAS, Holdings, the Company, each lender from time to time party thereto (the “Lenders”) and the Administrative Agent have entered into the Revolving Credit Agreement, dated as of August 11, 2025 (the “Credit Agreement”; capitalized terms not otherwise defined in this First Amendment have the same meanings assigned thereto in the Credit Agreement); and

…

EX-10.1·8-K·CIK 1306830·ACC 0001104659-26-090359·Filed Aug 04, 2026, 16:05 ET

EX-10.1

BranchOut Food Inc.

SETTLEMENT AGREEMENT AND GENERAL RELEASE

** **

This Settlement Agreement and General Release (the “Agreement”) is entered into by Branchout Food, Inc., a Nevada Corporation, (“Branchout”), John Dalfonsi (“Dalfonsi”), and Eric Healy (“Healy”), on the one hand, and Doug Durst (“Durst”) and Chase Innovations, Inc. (“Chase”), on the other (collectively “the Parties”). The Parties agree to execute any necessary documents to aid in the approval of the Agreement.

RECITALS

A. Durst is a former employee of Branchout. Durst filed suit against in Washington State King County Superior Court, Civil Action No. 25-2-18652-1-SEA (the “Lawsuit”) against Branchout, Dalfonsi, and Healy (collectively, Defendants) alleging breach of contract and failure to pay wages. Defendants denied the allegations and Branchout filed counterclaims against Durst alleging Breach of Contract and various tort claims.

B. The Parties now desire to settle, fully and finally, all differences between them.

…

EX-10.1·8-K·CIK 1962481·ACC 0001493152-26-035987·Filed Aug 04, 2026, 16:05 ET

EX-10.2

Seres Therapeutics, Inc.

***Execution Copy ***

***STOCK ISSUANCE AGREEMENT ***

This STOCK ISSUANCE AGREEMENT (this “Agreement”) is made and entered into as of July 31, 2026 by and between Seres Therapeutics, Inc., a Delaware corporation (the “Company”), and BMR-SIDNEY RESEARCH CAMPUS LLC, a Delaware limited liability company (the “Landlord”).

**RECITALS **

A. WHEREAS, the Company and the Landlord have entered into a Third Amendment to Lease and Termination Agreement, dated on or about the date hereof (the “Lease Termination Agreement”), pursuant to which the Company and the Landlord have agreed to terminate that certain Lease, dated as of November 11, 2015, as amended, by and between the Company and the Landlord;

…

EX-10.2·8-K·CIK 1609809·ACC 0001193125-26-332742·Filed Aug 04, 2026, 16:03 ET

EX-10.1

Seres Therapeutics, Inc.

**THIRD AMENDMENT TO LEASE AND TERMINATION AGREEMENT **

THIS THIRD AMENDMENT TO LEASE AND TERMINATION AGREEMENT (this “Agreement”) is entered into as of this 31st day of July, 2026 (“Execution Date”), by and between BMR-SIDNEY RESEARCH CAMPUS LLC, a Delaware limited liability company (“Landlord”), and SERES THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

**RECITALS **

A. WHEREAS, Landlord and Tenant entered into that certain Lease dated as of November 11, 2015, as amended by that certain First Amendment to Lease dated as of December 9, 2022, and that certain Second Amendment to Lease dated as of January 25, 2024 (as the same may have been further amended, amended and restated, supplemented or otherwise modified from time to time, the “Existing Lease”), whereby Tenant leases certain premises (the “Premises”) from Landlord in the building at 200 Sidney Street, Cambridge, Massachusetts (the “Building”); and

…

EX-10.1·8-K·CIK 1609809·ACC 0001193125-26-332742·Filed Aug 04, 2026, 16:03 ET

EXHIBIT 10.1

SSR MINING INC.

EXECUTION VERSION

SECOND AMENDED AND RESTATED CREDIT AGREEMENT

dated as of

July 31, 2026

among

SSR MINING INC.

as Borrower

and

THE LENDERS FROM TIME TO TIME PARTIES HERETO

as Lenders

and

THE BANK OF NOVA SCOTIA

as Administrative Agent

and

THE BANK OF NOVA SCOTIA AND CANADIAN IMPERIAL BANK OF COMMERCE

as Issuing Banks, Co-Lead Arrangers and Joint Bookrunners

and

ROYAL BANK OF CANADA AND BANK OF MONTREAL

as Co-Syndication Agents

TABLE OF CONTENTS

Page

** **

…

EX-10.1·8-K·CIK 921638·ACC 0001104659-26-090338·Filed Aug 04, 2026, 16:00 ET